High-valent iron-oxo species are thought to be intermediates in the catalytic cycles of oxygenases and peroxidases. An attractive route to these iron-oxo intermediates involves laser flash-quench oxidation of ferric hemes, as demonstrated by our work on the ferryl (compound II) and ferryl porphyrin radical cation (compound I) intermediates of horseradish peroxidase. Extension of this work to include cytochrome P450-BM3 (CYP102A1) has required covalent attachment of a Ru II photosensitizer to a nonnative cysteine near the heme (Ru II K97C -Fe III P450 ), in order to promote electron transfer from the Fe III porphyrin to photogenerated Ru III . The Ru II K97C -Fe III P450 conjugate was structurally characterized by X-ray crystallography (2.4 Å resolution; Ru-Fe distance, 24 Å). Flash-quench oxidation of the ferric-aquo heme produces an Fe IV -hydroxide species (compound II) within 2 ms. Difference spectra for three singly oxidized P450-BM3 intermediates were obtained from kinetics modeling of the transient absorption data in combination with generalized singular value decomposition analysis and multiexponential fitting.
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ruthenium bipyridine | enzyme catalysis T he cytochromes P450 constitute a superfamily of thiolateligated heme enzymes so named because the Soret absorption band in their CO-bound derivatives peaks near 450 nm. These monooxygenases catalyze a dazzling array of regio-and stereospecific oxidation reactions, including the hydroxylation of aliphatic and aromatic hydrocarbons and the epoxidation of alkenes (1, 2) . P450s take two reducing equivalents from NAD(P)H and deliver one atom from dioxygen to the organic substrate; the other oxygen atom is released as water. The consensus mechanism for P450 catalysis ( Fig. 1) implicates a ferryl porphyrin radical cation [compound I (CI): Fig. 1, intermediate 6] as the active oxygenating agent (3), but this elusive species has not been observed in P450 under single-turnover or steady-state catalytic conditions. In the postulated mechanism, CI is proposed to abstract a hydrogen atom from the substrate to form transient Fe IV -hydroxide complex (compound II, CII), followed by radical recombination to produce oxygenated product (4, 5) . Mechanistic studies of P450 catalysis in cryogenic matrices have suggested that the barrier to formation of CI (5 → 6) is higher than that for its reaction with substrate (6 → 7 → 1) (6). Consequently, recent efforts have focused on alternate routes to P450 CI that bypass the hydroperoxide intermediate (5) . One approach employs generation of CII using peroxynitrite, followed by laser flash photolysis to yield CI (7). This technique has been used in studies of the spectra and reactivity of the putative CI species, but the interpretation of the results remains open to question.
In earlier work, we employed ½RuðbpyÞ 3 2þ (bpy ¼ 2;2 0 -bipyridine) in a bimolecular flash-quench photochemical oxidation protocol to generate CII and CI in horseradish peroxidase (HRP) and the heme octapeptide from cyctochrome c (MP8) (8, 9) . This approach was unsuccessful with P450, however, owing to the deep burial of the heme inside the polypeptide matrix of the enzyme. We have circumvented this problem by covalently attaching a ruthenium-diimine photosensitizer to a nonnative cysteine residue on the P450 surface.
The structurally characterized soluble heme domain of P450-BM3 from Bacillus megaterium serves as a model for the mammalian proteins (10) . To ensure a unique attachment of the ruthenium-diimine photosensitizer to the P450, we have used site-directed mutagenesis to remove two native cysteine residues (C62A, C156S) and replace a surface lysine with cysteine at position 97 (K97C); this triple mutant has been overexpressed in Escherichia coli. The complex ½RuðbpyÞ 2 ðIA-phenÞ 2þ (IAphen ¼ 5-iodoacetamido-1;10-phenanthroline) was covalently coupled to Cys97 to give the conjugate Ru II K97C -Fe III P450 . This conjugate was characterized by mass spectrometry, UV-visible and luminescence spectroscopies, and X-ray crystallography. In our laser flash-quench experiments, this species undergoes rapid photooxidation of the resting ferric-aquo complex to form CII.
Results and Discussion X-Ray Crystal Structure Analysis We have determined the X-ray crystal structure of Ru II K97C -Fe III P450 to a resolution of 2.4 Å (Table S1 ). Two monomers were found in the asymmetric unit; the rmsd between the C α atom positions in the two monomers is 0.34 Å, confirming that the two polypeptides have nearly identical conformations. The Ru-photosensitizer is well defined only in one monomer of the crystal structure, owing to π-stacking of the bipyridine ligands with aromatic residues on adjacent crystal units. The Fe-Ru distance between the heme and Ru-photosensitizer is 24 Å (Fig. 2) . The Ru-photosensitizer in the second monomer, which lacks the π-stacking interactions with neighboring protein molecules, is highly disordered, possibly due to flexibility of the cysteine-acetamide linkage. These observations indicate a degree of conformational freedom for the Ru-photosensitizer. The 24-Å Ru-Fe distance is likely near the maximum separation in the distribution of conformations sampled by the Ru complex in dilute Ru II K97C -Fe III P450 solutions since the ligands of the photosensitizer may form favorable hydrophobic or π-stacking interactions with amino acid residues on the protein surface, decreasing the Fe-Ru separation. luminescence decay in the presence of an exogenous electron-transfer quencher (½RuðNH 3 Þ 6 3þ ) produces a quenching rate constant (k q ) of 1.4 × 10 9 M −1 s −1 (Fig. S2) .
We used transient absorption (TA) spectroscopy to characterize the intermediates formed following excitation of Ru II K97C -Fe III P450 ; measurements in the heme Soret region (390-440 nm) provide the largest TA signals. The Ru-diimine complex also contributes substantially to absorbance in this region, enabling us to monitor changes in both photosensitizer and heme oxidation states (Fig. S3) . TA traces of Ru II K97C -Fe III P450 following excitation in the absence of exogenous quencher (pH 8, λ ex ¼ 480 nm, 10 ns pulse) reveals bleaching (ΔAbs < 0) at wavelengths corresponding to Ru II absorption (390-440 nm), consistent with the well-characterized behavior of metal-to-ligand charge-transfer (MLCT) excited Ru-diimine complexes (13) . The transient signal returns to baseline at the same rate as luminescence decays and we find no evidence for transient species associated with changes in heme Soret absorption.
In the presence of quencher (17 mM ½RuðNH 3 Þ 6 3þ ), the TA kinetics become substantially more complex, revealing the presence of multiple intermediates that form and disappear over the microsecond to second time range (Fig. 3) . A generalized singular value decomposition analysis of the data (14) indicates that as many as five distinct kinetics phases contribute to the recovery of the TA signal (Fig. S4) . Global least-squares fitting of the TA data recorded at six different wavelengths to a sum of five exponentials with amplitude coefficients ρ 1-5 produces the observed rate constants γ 1-5 listed in Table 1 . We find analogous trends in the TA data recorded at pH 6 and 7. , and the second, Ru III K97C -Fe III P450 , is formed in the quenching reaction with ½RuðNH 3 Þ 6 3þ . The final species formed is Ru II K97C -Fe III P450 , because all TA signals return to baseline. Three transient species remain to be identified; we anticipate that these are associated with oxidation of the P450 heme center (P450 OX1-3 ) (Scheme 1).
In our studies of flash-quench CII generation in HRP and MP8, we found that ferryl-heme formation was preceded by a porphyrin oxidation step; subsequent internal rearrangement and deprotonation led to the Fe IV ðOÞP product. Based on this reasoning, we have developed a sequential kinetics model for the Ru II K97C -Fe III P450 TA data (Fig. 4) . We have solved the rate law for this model, allowing us to express the observed rate constants (γ 1-5 ) and amplitude coefficients (ρ 1-5 ) in terms of nine elementary rate constants Ru III -diimine constrain the possible values of k 1 and k 3 . The balance between k 5 and k 7 has no effect on the relative difference spectra extracted from the data, so k 5 was set equal to k 7 . The equilibrium constant K eq was optimized to provide the best agreement between the transient difference spectra recorded at the three different pH values (Fig. 5) .
The difference spectra of Ã Ru II K97C -Fe III P450 and Ru III K97C -Fe III P450 extracted from the kinetics analysis exhibit bleaching at 430 nm of the Ru II MLCT absorption band (Fig. S5) . Of primary interest are the difference spectra corresponding to intermediates P450 (Fig. S5) . The spectra of P450 OX1 and P450 OX2 are quite similar, characterized by a bleach of the Soret absorption band (centered at 420 nm). The spectrum of P450 OX2 displays somewhat more absorbance at 390 nm than that of P450 OX1 but otherwise closely resembles that of P450 OX1 . Reasoning by analogy to our results on the oxidation of HRP and MP8, and the similarity of their difference spectra, we suggest that P450 OX1 . These difference spectra are consistent with the difference spectrum of CPO CI, which is characterized as an Fe IV ðOÞP •þ center (15) . Flash-quench-triggered oxidation of HRP and MP8 produces a similarly bleached, six-coordinate ferric porphyrin radical cation (Fe III P •þ ) (8) . The blue shift in absorption for these porphyrin radical intermediates is also consistent with synthetic models of Fe(III)-porphyrin cation radicals (16) .
The specific rate of Fe III ðOH 2 ÞP
•þ ðAÞP450 formation in our conjugate (Table S2 ) is comparable to that found for reconstituted myoglobin containing a heme tethered directly to RuðbpyÞ 3 2þ (17) . This observation suggests that a favorable pathway couples the P450 porphyrin to Ru III , possibly involving the Trp96-heme propionate hydrogen bond (18 (19) .
The apparent equilibrium constant between P450 OX2 and P450 OX3 varies with pH (K eq : 0.8, pH 6; 2.9, pH 7; 10, pH 8) suggesting that a proton is lost in the formation of P450 OX3 . Moreover, the difference spectrum for this species indicates a red-shifted Soret absorption band analogous to that reported for the Fe IV ðOHÞP center in CPO CII (20) . Hence, we suggest that P450 OX3 is Ru II K97C -Fe IV ðOHÞP P450 . Internal charge transfer in Fe III ðOH 2 ÞP
•þ ðBÞP450 is accompanied by rapid loss of a proton (possibly to water), producing Fe IV ðOHÞP P450 . On the basis of results for HRP and MP8, we expect this heme rearrangement to be pH dependent. The formation of flash-quench-generated CII in HRP was slower (k obs of 4.1 s −1 ) due to rate-limiting water ligation. CII formation in P450 proceeds on the millisecond timescale because the sixth coordination site of the ferric heme is occupied by a water molecule. (Fig. 4 ), but it is not possible to determine the two rate constants because equilibration between Ru II K97C -Fe III ðOH 2 ÞP •þ ðBÞP450 and Ru II K97C -Fe IV ðOHÞ P P450 is faster than the ground-state recovery process. The precise nature of the ground-state recovery process remains unclear. It should be described by second-order reaction kinetics, but the experimental data are modeled better by a simple exponential process. Nevertheless, ½RuðNH 3 Þ 6 2þ seems to be involved in the recovery reaction because, in the presence of ½RuðNH 3 Þ 6 3þ as quencher, transient absorption data are consistent over the course of multiple hours, and the Soret absorption band appears relatively unaffected after many rounds of flash-quench excitation. However, similar measurements with an irreversible quencher (½CoðNH 3 Þ 5 Cl 3þ ) induces bleaching of the Soret band and rapid sample degradation.
Concluding Remarks
We have developed a flash-quench method to oxidize the buried resting state ferric-aquo compound of the P450-BM3 heme domain to CII without the use of reactive oxygen species (O 2 , H 2 O 2 ). The catalytic cycle runs in reverse by photochemically splitting water at the heme site. It is likely that the observed ferryl species is protonated over a pH range of 6-8, as consistent with the current view of chloroperoxidase and P450 CII. The finding that internal oxidation of the iron center is rate limiting has allowed us to observe porphyrin radical cation intermediates. As porphyrin oxidation occurs on the microsecond timescale, we can reasonably expect a second round of flash-quench on photochemically generated CII to produce CI.
Materials and Methods
Protein Expression. A plasmid containing the C62A/C156S double mutant of the P450-BM3 heme domain in the vector pCWori þ was obtained courtesy of Andrew Udit (Occidental College, Los Angeles, CA). A cysteine residue for photosensitizer coupling was introduced at residue 97 using a QuikChange Site-Directed Mutagenesis kit (Qiagen). All primers were purchased from Operon. Mutant cytochromes were expressed with an N-terminal His 6 tag in Escherichia coli BL21(DE3) cells and purified according to literature procedure (21) . Proteins were characterized by SDS-PAGE and MS analysis.
Photosensitizer Synthesis and Coupling to P450-BM3. Ruthenium(II) bisbipyridine 5-acetamido-1,10-phenanthroline (½RuðbpyÞ 2 ðIA-phenÞ 2þ ) was synthesized according to the published procedure (22) with the following modification: In lieu of final precipitation as the PF 6 salt, the compound was redissolved in water without further purification. Approximately twofold excess of ½RuðbpyÞ 2 ðIA-phenÞ 2þ was added to a 20 μM solution of C62A/C156S/K97C P450-BM3 in 20 mM Tris buffer (pH 8), and shaken in the dark at 4°C. Labeling progress was monitored by MALDI mass spectro- (vol∕vol) . Crystals formed over a period of 2 d at 4°C, and were flash-frozen directly from the crystallization solution. X-ray diffraction data were collected at 100 K using beamline 7-1 at the Stanford Synchrotron Radiation Laboratory. Detailed description of the structure determination is provided in the SI Text. Statistics for data collection and refinement are shown in Table S1 . Atomic coordinates and structure factors were deposited in the Protein Data Bank under the entry 3NPL.
Laser Flash-Quench. Samples consisting of ½RuðbpyÞ 2 ðIA-phenÞ 2þ or Ru II K97C -Fe P450 (∼10 μM) with and without quencher (17 mM ruthenium(III)-hexaammine trichloride) were prepared in buffered solution (pH 6, 20 mM sodium acetate; pH 7, 20 mM sodium acetate; pH 8, 50 mM sodium borate or 50 mM Tris). Deoxygenation was achieved via 30 gentle pump-backfill cycles with argon. Samples were excited with 10 ns laser pulses at 480 nm, delivered by an optical parametric oscillator pumped by the third harmonic from a Spectra Physics Q-switched Nd:YAG laser. Luminescence decays were monitored at 630 nm. Single wavelength TA kinetics were monitored every 10 nm from 390-440 nm, averaging ∼500 shots per wavelength. Data from five separate timescales (2 μs, 40 μs, 400 μs, 10 ms, and 500 ms) were collected and spliced together to produce full kinetics traces. 
